Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive models of choroidal neovascularization and geographic atrophy incidence applied to clinical trial design.

American journal of ophthalmology - 1 Sept 2012

McCarthy Linda C, Newcombe Paul J, Whittaker John C, Wurzelmann John I, Fries Michael A, Burnham Nancy R, Cai Gengqian, Stinnett Sandra W, Trivedi Trupti M, Xu Chun-Fang

Abstract excerpt

PURPOSE: To develop comprehensive predictive models for choroidal neovascularization (CNV) and geographic atrophy (GA) incidence within 3 years that can be applied realistically to clinical practice. DESIGN: Retrospective evaluation of data from a longitudinal study to develop and validate predic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to Choroidal Neovascularization

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to False Positive Reactions

Share to Geographic Atrophy

Share to Models, Statistical

Share to Research Design

Share to ROC Curve

Source

Identifiers

PMID: 22704140
DOI: 10.1016/j.ajo.2012.03.021

Genes

CFH
ARMS2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22704140-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive models of choroidal neovascularization and geographic atrophy incidence applied to clinical trial design.PMID 22704140Read ↗

Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.Semantic proximity Read ↗

Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.Semantic proximity Read ↗

Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy.Semantic proximity Read ↗

Risk assessment model for development of advanced age-related macular degeneration.Semantic proximity Read ↗

Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration.Semantic proximity Read ↗

Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores.Semantic proximity Read ↗

Differences in the Genetic Susceptibility to Age-Related Macular Degeneration Clinical Subtypes.Semantic proximity Read ↗

AMD Genetics: Methods and Analyses for Association, Progression, and Prediction.Semantic proximity Read ↗

Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration.Semantic proximity Read ↗

Rare and Common Genetic Variants, Smoking and Higher Body Mass Index Are Associated with Earlier Age of Progression to Geographic Atrophy and Neovascular Advanced Stages of Macular Degeneration in a Prospective AnalysisSemantic proximity Read ↗

Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors.Semantic proximity Read ↗

Suitability of Machine Learning for Atrophy and Fibrosis Development in Neovascular Age-Related Macular DegenerationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.